Deutsches Herzzentrum Muenchen - Recruiting 18 years or older. - Randomized Trial of Stenting After Dilation With or Without Paclitaxel Eluting Balloon or Atherectomy in Patients With Symptomatic Peripheral Artery Disease.
Arteriocyte, Inc. - Recruiting 18 years to 85 years. - Phase I, Non-Randomized, Feasibility Study for the Use of Bone Marrow Cell Concentrate Prepared Using the Magellan System for the Treatment of Critical Limb Ischemia.
Ethicon, Inc. - Recruiting 18 years or older. - A Prospective, Single-Arm, Observational, Non-interventional Study for EVICEL T Fibrin Sealant (Human) When Used as an Adjunct to Haemostasis in Vascular Surgery.
Humacyte, Inc. - Recruiting 18 years to 80 years. - A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft as an Above-Knee Femoro-Popliteal Bypass Graft in Patients With Peripheral Arterial Disease.
Yaffa Golan, Ltd. - Recruiting 18 years or older. - A Pilot Study to Assess the Use of the Magic Foot in the Improvement of Subjective and Objective Parameters in Subjects With Foot Symptoms as a Result of Diabetes or Peripheral Vascular Disease..
University of British Columbia - Recruiting 30 years or older. - Early Post-Operative Dysglycemia in Patients With and Without Diabetes Post-Infrainguinal Bypass Surgery and the Effectiveness of a Diabetes Action Team in the Management of Diabetes Post Infrainguinal Bypass Surgery on Glycemic Control, Length of Stay, and Infection Rates: A Pilot Study.
Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive standard diabetes care by their admitting physician; Subjects with diabetes who plan to undergo elective infrainguinal bypass surgery will receive diabetes care under the direction of the Diabetes Action Team; Subjects without diabetes will have their blood glucose levels monitored while in the hospital